Literature DB >> 18946757

Role of tumor angiogenesis in gallbladder carcinoma: with special reference to thymidine phosphorylase.

Yukari Harino1, Satoru Imura, Hirofumi Kanemura, Yuji Morine, Masahiko Fujii, Toru Ikegami, Hisanori Uehara, Mitsuo Shimada.   

Abstract

BACKGROUND: Angiogenesis plays an important role in tumor growth and metastasis. Thymidine phosphorylase (TP), as well as vascular endothelial growth factor (VEGF), is known to be an angiogenic factor. The aim of this study was to clarify whether TP regulates angiogenesis and to determine the clinicopathological role of TP expression in gallbladder cancer.
METHODS: Thirty-seven patients with gallbladder cancer who underwent curative surgical resection were included in this study, and we evaluated results in 21 of these patients in whom TP gene expression could be measured. Intratumoral TP gene expression was evaluated using the Danenberg tumor profile method. TP gene expression was classified into two groups according to median values: high and low. Tissue TP expression was classified into two groups (positive and negative) by a pathologist. Clinicopathological variables were compared between groups with high and low TP gene expression (TP high and TP low groups).
RESULTS: No correlation was observed between TP gene expression (high and low groups) and any clinicopathological variables except survival rate. However, the survival rate was significantly lower in the TP high group (P<0.05). TP gene expression was associated with tissue TP expression evaluated by immunohistochemical staining (P<0.05). In addition, tumor microvessel density was significantly higher in the TP high group (P<0.05).
CONCLUSION: Expression of the TP gene in gallbladder carcinoma is associated with angiogenesis and may be a new independent prognostic parameter.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18946757     DOI: 10.1007/s10147-008-0778-y

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  24 in total

1.  Thymidylate synthase and dihydropyrimidine dehydrogenase gene expression in relation to differentiation of gastric cancer.

Authors:  Wataru Ichikawa; Takehiro Takahashi; Kenichi Suto; Zenro Nihei; Yoshinori Shirota; Michio Shimizu; Yasutsuna Sasaki; Renzo Hirayama
Journal:  Int J Cancer       Date:  2004-12-20       Impact factor: 7.396

2.  Real time quantitative PCR.

Authors:  C A Heid; J Stevens; K J Livak; P M Williams
Journal:  Genome Res       Date:  1996-10       Impact factor: 9.043

3.  Expression of thymidylate synthase, dihydropyrimidine dehydrogenase, thymidine phosphorylase, and orotate phosphoribosyl transferase in prostate cancer.

Authors:  Y Miyoshi; H Uemura; H Ishiguro; H Kitamura; N Nomura; P V Danenberg; Y Kubota
Journal:  Prostate Cancer Prostatic Dis       Date:  2005       Impact factor: 5.554

4.  Identification of angiogenic activity and the cloning and expression of platelet-derived endothelial cell growth factor.

Authors:  F Ishikawa; K Miyazono; U Hellman; H Drexler; C Wernstedt; K Hagiwara; K Usuki; F Takaku; W Risau; C H Heldin
Journal:  Nature       Date:  1989-04-13       Impact factor: 49.962

5.  Expression of platelet-derived endothelial cell growth factor/thymidine phosphorylase in human gallbladder lesions.

Authors:  S Yamamoto; Y Kitadai; A Tsuchida; T Sasaki; K Matsubara; G Kajiyama
Journal:  Eur J Cancer       Date:  2000-01       Impact factor: 9.162

Review 6.  Pathogenesis of tumor stroma generation: a critical role for leaky blood vessels and fibrin deposition.

Authors:  J A Nagy; L F Brown; D R Senger; N Lanir; L Van de Water; A M Dvorak; H F Dvorak
Journal:  Biochim Biophys Acta       Date:  1989-02

7.  Tumor angiogenesis in gallbladder carcinoma.

Authors:  Y Sugawara; M Makuuchi; Y Harihara; T Noie; K Inoue; K Kubota; T Takayama
Journal:  Hepatogastroenterology       Date:  1999 May-Jun

8.  Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.

Authors:  M I Koukourakis; A Giatromanolaki; G Fountzilas; E Sivridis; K C Gatter; A L Harris
Journal:  Clin Cancer Res       Date:  2000-02       Impact factor: 12.531

9.  Immunohistochemical analysis of transforming growth factor beta in gallbladder cancer.

Authors:  Keiichi Kitamura; Kazuhiko Kasuya; Akihiko Tsuchida; Akihiro Mimuro; Keiichiro Inoue; Toshiaki Aoki; Tatsuya Aoki; Yasuhisa Koyanagi
Journal:  Oncol Rep       Date:  2003 Mar-Apr       Impact factor: 3.906

Review 10.  The role of thymidine phosphorylase, an angiogenic enzyme, in tumor progression.

Authors:  Shin-ichi Akiyama; Tatsuhiko Furukawa; Tomoyuki Sumizawa; Yuji Takebayashi; Yuichi Nakajima; Shunji Shimaoka; Misako Haraguchi
Journal:  Cancer Sci       Date:  2004-11       Impact factor: 6.716

View more
  4 in total

1.  Regional differences in gallbladder cancer pathogenesis: insights from a comparison of cell cycle-regulatory, PI3K, and pro-angiogenic protein expression.

Authors:  Jean M Butte; Javiera Torres; Emanuela F Veras; Kenichi Matsuo; Mithat Gönen; Michael I D'Angelica; Enrique Waugh; Manuel Meneses; Yoshiyaki Inayama; Yuman Fong; Ronald P Dematteo; Hernan De La Fuente; Itaru Endo; David S Klimstra; William R Jarnagin
Journal:  Ann Surg Oncol       Date:  2012-12-01       Impact factor: 5.344

Review 2.  Targeting Angiogenesis in Biliary Tract Cancers: An Open Option.

Authors:  Valeria Simone; Oronzo Brunetti; Luigi Lupo; Mario Testini; Eugenio Maiorano; Michele Simone; Vito Longo; Christian Rolfo; Marc Peeters; Aldo Scarpa; Amalia Azzariti; Antonio Russo; Domenico Ribatti; Nicola Silvestris
Journal:  Int J Mol Sci       Date:  2017-02-15       Impact factor: 5.923

Review 3.  The dual role of thymidine phosphorylase in cancer development and chemotherapy.

Authors:  Annelies Bronckaers; Federico Gago; Jan Balzarini; Sandra Liekens
Journal:  Med Res Rev       Date:  2009-11       Impact factor: 12.944

4.  Molecular biology of gallbladder cancer: potential clinical implications.

Authors:  Ake Andrén-Sandberg
Journal:  N Am J Med Sci       Date:  2012-10
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.